PEN FY 2023 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.1B+25.0% YoY

Gross Profit

$683M64.5% margin

Operating Income

$74M6.9% margin

Net Income

$91M8.6% margin

EPS (Diluted)

$2.32

Cash Flow

Operating Cash Flow

$97M

Free Cash Flow

$82M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$377M

Stockholders' Equity

$1.2B

Cash & Equivalents

$167M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$847M	+25.0%
Gross Profit	$683M	$535M	+27.5%
Operating Income	$74M	$6M	+1109.3%
Net Income	$91M	-$2M	+4643.2%